← Back to Search

Behavioural Intervention

Brain Training Program for Healthy Aging (INHANCE Trial)

N/A
Waitlist Available
Led By Thomas Van Vleet, PhD
Research Sponsored by Posit Science Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Potential participant must be 65+ years old at the time of study screening
Potential participant must be 65+ years old at the time of study screening.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 0 months (pre-intervention), at 3 months (post-intervention) and at 6 months (follow-up)
Awards & highlights

INHANCE Trial Summary

This trial will test if a computerized brain training program can improve neurological health in older adults.

Who is the study for?
This trial is for individuals aged 65 or older with no major neurocognitive disorders and a score of ≥ 23 on the MoCA. Participants must be able to use a computer and have WiFi access. They should not have used certain cognitive training programs in the past 5 years, be involved in other clinical trials that could affect this study's outcome, or have medical conditions that interfere with cognition.Check my eligibility
What is being tested?
The study tests INHANCE, a neuroplasticity-based cognitive training program against commercially available alternatives to improve neurological health in older adults. It assesses whether these exercises can enhance brain function through regular computerized activities.See study design
What are the potential side effects?
Since this trial involves non-invasive computerized cognitive training, there are minimal expected side effects. However, participants may experience eye strain or mild frustration during the exercises.

INHANCE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
I am 65 years old or older.

INHANCE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 0 months (pre-intervention), at 3 months (post-intervention) and at 6 months (follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 0 months (pre-intervention), at 3 months (post-intervention) and at 6 months (follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in FEOVB uptake through PET Imaging
Other outcome measures
Change in EXAMINER Executive Composite Score
Change in Heart Rate Variability
Change in Pupillometry
+3 more

INHANCE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental TreatmentExperimental Treatment1 Intervention
Computerized plasticity-based adaptive cognitive training requiring a total maximum of 70 treatment sessions, up to 7 sessions per week, 30 minutes per session.
Group II: Active ComparatorActive Control1 Intervention
Commercially available computerized training requiring a total maximum of 70 treatment sessions, up to 7 sessions per week, 30 minutes per session.

Find a Location

Who is running the clinical trial?

Posit Science CorporationLead Sponsor
38 Previous Clinical Trials
4,116 Total Patients Enrolled
McGill UniversityOTHER
395 Previous Clinical Trials
999,285 Total Patients Enrolled
1 Trials studying Healthy Aging
24 Patients Enrolled for Healthy Aging
Thomas Van Vleet, PhDPrincipal InvestigatorPosit Science Corporation
7 Previous Clinical Trials
502 Total Patients Enrolled

Media Library

INHANCE (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04149457 — N/A
Healthy Aging Research Study Groups: Experimental Treatment, Active Comparator
Healthy Aging Clinical Trial 2023: INHANCE Highlights & Side Effects. Trial Name: NCT04149457 — N/A
INHANCE (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04149457 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are taking part in this exploration?

"Affirmative. The clinical trial is currently recruiting, according to the data hosted on clinicaltrials.gov. This study was first launched on July 16th 2021 and has since been updated as recently as September 8th 2022 with a goal of finding 92 participants from one medical centre."

Answered by AI

Is this experiment actively enrolling new participants?

"Affirmative. The clinicaltrials.gov website states that this trial is currently sourcing for participants, first listed on July 16th 2021 and last modified on September 8th 2022. There are 92 openings at a single site available to patients who wish to take part in the study."

Answered by AI

Who else is applying?

What state do they live in?
Massachusetts
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Improving Neurological Health in Aging Via Neuroplasticity-based Computerized Exercise
2021. "Improving Neurological Health in Aging Via Neuroplasticity-based Computerized Exercise". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04149457.
~3 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top